On any given morning in Mumbai’s Shivaji Park, power-walkers circle the running track, fitness watches buzzing with every step. Minutes later, some drift toward nearby food stalls, where oil sizzles ...

Feb 5 (Reuters) - Indian drugmaker Alembic Pharmaceuticals on Thursday reported lower third‑quarter profit on Thursday after ...

Feb 3 (Reuters) - Indian drugmaker Mankind Pharma reported a higher third-quarter profit on Tuesday, driven by strong ...

As supply chain vulnerabilities intensify and competition accelerates, the cost of this underutilization could risk India's ...

This article is authored by Tushar Gupta, COO, Jubilant Biosys Limited (CRDMO).

India and the US have signed an interim trade pact cutting tariffs to 18%, with zero-duty benefits for pharma, gems, ...

The US-India interim trade deal provisionally continues to protect Indian pharmaceutical exports from Washington's reciprocal ...

Biostin Pharma, Ahmedabad, is a WHO GMP-certified third-party pharma manufacturer committed to delivering high-quality pharmaceutical products to both Indian and international traders. With our ...

In an agreement that seemingly bodes well for the flow of pharmaceuticals between the two regions, the EU and India on Monday agreed to a sweeping free trade agreement that the European bloc has ...

An interim India-US trade arrangement offers clarity to India's pharma sector, keeping medicines out of reciprocal tariffs.

The interim India-US trade agreement is expected to strengthen cooperation in pharmaceuticals and medical technology, with ...

India's FTA with the EU boosts textiles, pharma, and agriculture exports, enhancing competitiveness and safeguarding local industries.